We develop active ingredients and dietary supplements
based on the regulatory peptide technology.
Our experts are engaged in testing and deploying technologies in the industrial production, arrange for both pre-clinical and clinical examinations.
The company structure includes 15 high-quality laboratories combined in three departments, biogerontology, cell biology and clinical research.
Years of experience in the use of peptide bioregulators in health care has shown the high efficiency of this class of substances for various diseases.
Research, design and experimental development
Garmonia LLC performs a full cycle of operations from the development and research of a drug to mass production and marketing support. The company's key focus is on the search, design and experimental study of peptide drugs with high pharmacological activity and without any analogues in the world in some cases.
Let's create the future together
We invite to cooperation scientific and research centres for joint experiments in the field of genetics, cell biology and protein research.
Leave your details and we shall contact you shortly
privacy policy
At the moment, the company owns the rights to 80 product units, which are nutritional supplements and cosmetics as well as highly effective drugs that are under development.
We actively share our expertise on relevant biotechnology issues, engage in major international conferences and congresses by attracting the attention of foreign experts to contribute to the creation of new areas in the global biotechnology sector.
Many years of experience in the use of peptide bioregulators in public health have shown high efficiency of this class of substances in various diseases and pathological conditions including diseases that do not answer to the medical treatment with other drugs. Our company professionals have authored more than 1,000 scientific publications including 30 monographs and 213 patents in the field of gerontology, biotechnology and immunology.
The department's laboratories conduct molecular biological research into the structural and functional set-up of the diffuse neuroimmune-endocrine system and the genetic mechanisms of the neuroprotective action of peptide bioregulators...
The department's laboratories conduct molecular biological research into the structural and functional set-up of the diffuse neuroimmune-endocrine system and the genetic mechanisms of the neuroprotective action of peptide bioregulators...
the study on the mechanisms of USPs transport into cells with the participation of PEPT peptide transporters and LAT amino acid transporters is an urgent task for biophysics and molecular medicine.
The main aim of this review is to analyze the possible epigenetic mechanisms of the neuroprotective action of ultrashort peptides in AD. The review highlights the role of short peptides in the AD pathophysiology.
We are glad to inform you that one of the major events in the field of peptide bioregulation took place in England last month.
New publication in a special issue of "Molecules" - "Peptide Regulation of Gene Expression: A Systematic Review". A rather full review of major short peptides and their biological activity.
New publication: "Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease", which was published in the special issue "Epigenetic Drugs" of journal "Pharmaceuticals" (Q1, IF=4,286)
International journal Molecules has published our recent article: "EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease".
Vitual Laboratories is our official partner in the development and promotion of a new class of dietary supplements - complexes of natural peptide extracts. The specialists of our companies have been developing new formulas for several years and now we are happy to present them to you ...
The editors of Science magazine published our letter under the heading "Ultra short peptides again / Ultra short peptides overlooked again ", which was sent to the editorial board in the light of a recent article.
Peptides as molecules to treat COVID-19
Our company has begun a study that will identify possible molecular targets in human lung cells and in the SARS-CoV-2 virus that can be affected by peptides, and evaluate the possibility of using peptides as innovative drugs for the treatment of COVID-19 coronavirus infection.
Over 20 world-renowned experts, scientists and project leaders gave speeches in the course of two symposium in Dubai, UAE. The symposium provided a platform for discussion of latest research achievements in the field of preventive medicine. The lectures presented by our company made a big impact and will lead to new scientific partnerships.
Short peptides are molecules with small molecular weight, capable of penetrating the cell membrane and nuclear membrane for epigenetic regulation of gene expression, including the genes responsible for cell differentiation. The direction of cell differentiation induction depends on the peptide structure and concentration.
A large variety of short biologically active peptides possesses antioxidant, antibacterial, antitumour, anti-ageing and anti-inflammatory activity, involved in the regulation of neuro-immuno-endocrine system functions, cell apoptosis, proliferation and differentiation.
Primary stem cells, after several cell divisions, enter into a senescence state, that is characterized by alterations to spindle-shape typical morphology. This concern is one of the main problems in the use of human mesenchymal stem cells (hMSCs) in clinical applications which demand cells in large numbers.
Our company participated with 3 key speeches in the international forum "Productive longevity: Evidence based medicine and transdisciplinary synthesis, in Moscow 17-18 october. The forum took place in the FSBI «The Research Center for Obstetrics, Gynaecology and Perinatology» named after Academician V.I. Kulakov»
The YOUTH GEMS® line of cosmetics - with peptides and ginseng - is a specially developed programme for comprehensive care for the skin of the face, neck, décolleté and body. The composition of cosmetic products in the series includes unique active ingredients, such as short peptides, which have a targeted tissue-specific effect on all the basic structures of the skin.
Vitafoods Asia shapes the food industry for optimal health through science and innovation. Asia's No.1 nutraceutical event connects over 350 international suppliers and 6,000+ business leaders who are looking to source the most innovative and highest quality nutraceutical ingredients, dietary supplements and services.
Previous investigations demonstrated the ability of EDR peptide (Glu-Asp-Arg) to penetrate a cell nucleus and stimulate gene expression. The data obtained prompt EDR peptide capability to restore the morphology of spines in striatum neurons in Huntington's disease (HD) mouse model. EDR peptide has been shown by us to bind the DNA in solution and in a computer model.
Clinical effectivness of Endoluten peptide
The average effectiveness of Endolutene according to clinical and experimental data (endocrinology): 44%. According to clinical and experimental data (cardiology, epithalamin) - 211%.

Efficacy is revealed in patients with physiogenic asthenia and complex diseases after chemical and radiation therapy. The average efficiency in all clinical indicators is 53%. In organotypic cultures of the epiphysis of rats, Endoluten provided a 35% growth of the epiphysis explant zones.
The congress theme is 'Towards Capability in Ageing – from cell to society'. The theme emphasizes our ability to perform actions in order to reach valued goals within the macro, meso, and micro contexts.
The congress is the natural meeting place for researchers and professionals engaged in various scientific enquires and aging matters; whether in biological science, medical and health sciences, social sciences, in humanities or aging services.
International school of gerontology and geriatrics
The VII International School on Gerontology and Geriatrics of the International Institute of Aging, UN-Malta was held in St. Petersburg from April 8 to 13, 2019. The program of the school includes lectures by leading scientists and specialists in gerontology and geriatrics from Austria, Malta, Great Britain and Russia.